Board of Directors

Board of Directors

A diverse team of industry executives and business leaders, our board of directors serves to oversee Life Line Screening and ensure its continued success in the field of preventive health screenings.

Board of Directors

A diverse team of industry executives and business leaders, our board of directors serves to oversee Life Line Screening and ensure its continued success in the field of preventive health screenings.

Colin Scully, Chairman

Mr. Scully co-founded Life Line Screening of America in 1996 with Tim Phillips. The company has since become the nation’s leading provider of preventive health screenings and employs over 1,000 employees.

Mr. Scully’s leadership helped define a new model of health care in which highly trained healthcare professionals provide preventive screenings in local communities, a business model that emphasizes convenience and affordability. The new community-based platform of care has revolutionized the screening industry. It has also demonstrated the viability of an alternative health care model that is oriented around the consumer.

Mr. Scully is a graduate of The Ohio State University where he earned a Bachelor of Science degree in Business Administration and Marketing. During that time, he also completed Officer Candidate School with the United States Marine Corps.

Timothy Phillips

Mr. Phillips co-founded Life Line Screening of America in 1996 with Colin Scully. Mr Phillips led the Sales and Marketing for the company for the first 12 years of the company’s existence, and is currently an advisor to the CEO and a member of the Board of Directors.

Before co-founding Life Line Screening, Mr.Phillips was an assistant football coach at the University of Kansas. Mr. Phillips holds a Bachelor of Science Degree from Kent State University in Business Administration with a concentration in Finance

Jason Trevisan, Partner, Polaris Venture Partners

Jason Trevisan has been with Polaris Venture Partners since 2003. He focuses on growth equity investments and buyout opportunities in Internet, technology, healthcare, and media sectors.

Prior to joining Polaris Jason held various management roles in Analytics and Client Services at aQuantive (acquired by Microsoft in 2007). During his tenure at aQuantive Jason managed client relationships in industries including ecommerce, media/entertainment, pharmaceuticals, financial services and consumer products. Prior to aQuantive, he was a consultant with Bain & Company. While at Bain he consulted to private equity firms and Fortune 500 companies in technology, media, financial services and consumerproducts.

In addition to Life Line Screening, Jason is on the Board of Directors of Legalzoom, PartsSource, SnappCloud and ShoeDazzle. Jason received his M.B.A. with Distinction from the Tuck School of Business at Dartmouth, where he was recognized as an Edward Tuck Scholar. He graduated cum laude with an A.B. in English from Duke University.

John B. Ziegler

John B. Ziegler retired in January 2006 as the President, Worldwide Consumer Healthcare, of GlaxoSmithKline plc (the parent of SmithKline Beecham plc).

Mr. Ziegler joined SmithKline Beecham in 1991 as the head of SB Consumer Healthcare -North American Division. He was Executive Vice President of SmithKline Beecham from 1996 to 1998 and became President, Worldwide Consumer Healthcare in 1998. He has been a director of Quest Diagnostics since May 2000. Mr. Ziegler has been recommended by SmithKline Beecham for nomination as a director of Quest Diagnostics pursuant to the Stockholders Agreement with SmithKline Beecham.

He has extensive executive experience, including in sales, marketing, strategic planning and international operations, with multinational corporations operating in the health care industry.

Paul Gabos, Chief Financial Officer, Lincare

Paul G. Gabos has been a member of the Life Line Screening BOD since 2007. From 1997-2012, Mr. Gabos was Chief Financial Officer of Lincare Holdings Inc. (NASDAQ:LNCR), a home healthcare services company with approximately $2.0 billion in annual revenues. He worked at Lincare for nearly 20 years, retiring in 2012 following the acquisition of Lincare by The Linde Group AG, a transaction valued at $4.7 billion.

Mr. Gabos is a member (since 2002) of the Board of Directors of MEDNAX, Inc. (NYSE: MD), a physician practice management company, where he serves as Audit Committee Chairman and a member of the Executive Committee of the Board. In August 2013, he became a member of the Board of Directors of Health Insurance Innovations, Inc. (NASDAQ: HIIQ), a developer and administrator of affordable individual health insurance and discount benefit plans, and serves as its Chairman of the Board and Audit Committee Chairman. Mr. Gabos also serves on the boards of Airo Brands (since 2018) and Kaliber Labs (since 2017).

Prior to his employment with Lincare, he was a merger and acquisition specialist with Dean Witter Reynolds Inc. and worked for Coopers & Lybrand. Mr. Gabos holds a B.S. in Economics from The Wharton School of the University of Pennsylvania.

Peter Barton Hutt, Senior Counsel, Covington & Burling LLP

Peter Barton Hutt is a senior counsel in the Washington, D.C. law firm of Covington & BurlingLLP specializing in Food and Drug Law. He graduated from Yale College and Harvard Law School and obtained a Master of Laws degree in Food and Drug Law from NYU Law School.

Peter Barton Hutt is a senior counsel in the Washington, D.C. law firm of Covington & Burling LLP specializing in Food and Drug Law. He graduated from Yale College and Harvard Law School and obtained a Master of Laws degree in Food and Drug Law from NYU Law School. Mr. Hutt served as Chief Counsel for the Food and Drug Administration during 1971-1975.

He is the co-author of the casebook used to teach food and drug law throughout the country, and has published more than 175 book chapters and articles on food and drug law and health policy. Beginning in 1994 he has taught a full course on this subject during Winter Term at Harvard Law School, and in 1998 he taught the same course during Spring Term at Stanford LawSchool. Mr. Hutt has been a member of the Institute of Medicine since it was founded in 1971.

He serves on academic, philanthropy, and venture capital advisory boards, and the boards of startup biotechnology companies.

Rakesh K. Kaul, Advisor

Rakesh K. Kaul is Chairman of Innovairre,a leading marketing services company. He is also Chairman of Spherenomics LLC,which since 2001 has focused on incubating ventures in a principal capacity,including serving on the Boards of Estee Advisors, Income Discovery, Ibby’s, and Hridei. From 2007 to 2010 he served as Senior Advisor to The Carlyle Group. He served as Senior Advisor and Board Member of Oriental Trading Co.,a $600MM direct/ecommerce marketer of Educational and Party Goods Supplies from 2007 to 2011. He was President and Chief Executive Officer and member of the Board of Directors for Hanover Direct, Inc. in Weehawken, New Jersey, from March 1996 to December 2000.

Starting in 1992, Rakesh served as Executive Vice President, Chief Administrative Officer, and member of the Board of Directors for Fingerhut Companies in Minneapolis. In 1994, Rakesh was promoted to Vice Chairman and promoted again in 1995 to Chief Operating Officer where he served until March 1996. He was the Founder of Metris Credit Card companies.

Rakesh received his undergraduate degree from the Indian Institute of Technology in New Delhi, India. He received hisM.S. from Brown University and his M.B.A. from the University of Chicago. He has passed the CPA exam from the State of California.

As a global executive, Rakesh has worked extensively in Japan, China, India, Canada and the U.S. in the areas of consumer products, retailing, e-commerce and consumer finance.

Terrance G. McGuire, Co-founder and General Partner, Polaris Venture Partners

As a Founding Partner of Polaris Partners, Terry McGuire brings more than 25 years of successful early stage investing experience in medical and information technology companies.

Terry has invested in more than 50 companies. He co-founded Inspire Pharmaceuticals (public and sold to Merck), AIR (sold to Alkermes) and MicroCHIPS (private). Companies Terry has supported have touched more than 60 million patients and saved over 400,000 lives. These companies have raised over $6 billion in equity and corporate capital. As a group, they have achieved a combined peak enterprise value of over $50 billion.

In 2015, Terry was listed as one of Scientific American's Worldview 100, visionaries who continue to reshape biotechnology and the world. In 2014, Terry was chosen to receive the Irish America Healthcare & Life Sciences 50 Award. In 2013, Terry was listed as one of Forbes' Top Life Sciences Investors. In 2011, Terry was listed in Forbes' Midas 100 List of Top Tech Investors. He is also a recipient of the Massachusetts Society for Medical Research Award, and the Albert Einstein Award for Outstanding Achievement in the Life Sciences, awarded by Harvard and the City of Jerusalem. He was awarded honorary doctorate degrees from Ohio Wesleyan University and Canisius College for his work in translational science.

Terry is emeritus Chairman of the National Venture Capital Association.

Terry is chairman of the Thayer School of Engineering, Dartmouth College. He also sits on the boards of MIT's The David H. Koch Institute for Integrative Cancer Research, The Arthur Rock Center for Entrepreneurship at Harvard Business School, and The Healthcare Initiative Advisory Board (HBS).

Terry holds an MBA from Harvard Business School, an MS in engineering from The Thayer School at Dartmouth College, and a BS in physics and economics from Hobart College

See Our Other Teams

Read more about the expertise of our Executive and Clinical Team Members.